PT  - JOURNAL ARTICLE
AU  - Hagai Rossman
AU  - Smadar Shilo
AU  - Tomer Meir
AU  - Malka Gorfine
AU  - Uri Shalit
AU  - Eran Segal
TI  - Patterns of COVID-19 pandemic dynamics following deployment of a broad national immunization program
AID  - 10.1101/2021.02.08.21251325
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.08.21251325
4099  - http://medrxiv.org/content/early/2021/03/08/2021.02.08.21251325.short
4100  - http://medrxiv.org/content/early/2021/03/08/2021.02.08.21251325.full
AB  - Studies on the real-life impact of the BNT162b2 vaccine, recently authorized for the prevention of coronavirus disease 2019 (COVID-19), are urgently needed. Here, we analysed the temporal dynamics of the number of new COVID-19 cases and hospitalization in Israel following a rapid vaccination campaign initiated on December 20th, 2020. We conducted a retrospective descriptive analysis of data originating from the Israeli Ministry of Health (MOH) from March 2020 to February 2021. In order to distill the possible effect of the vaccinations from other factors, including a third lockdown imposed in Israel on January 2021, we compared the time-dependent changes in number of COVID-19 cases and hospitalizations between (1) individuals aged 60 years and older, eligible to receive the vaccine earlier, and younger age groups; (2) the latest lockdown (which was imposed in parallel to the vaccine rollout) versus the previous lockdown, imposed on September 2020; (3) early-vaccinated cities compared to late-vaccinated cities; and (4) early-vaccinated geographical statistical areas (GSAs) compared to late-vaccinated GSAs. In mid-January, the number of COVID-19 cases and hospitalization started to decline, with a larger and earlier decrease among older individuals, followed by younger age groups, by the order in which they were prioritized for vaccination. This fast and early decline in older individuals was more evident in early-vaccinated compared to late-vaccinated cities. Such a pattern was not observed in the previous lockdown. Our analysis demonstrates evidence for the real-life impact of a national vaccination campaign in Israel on the pandemic dynamics. We believe that our findings have major public health implications in the struggle against the COVID-19 pandemic, including the public ’s perception of the need for and benefit of nationwide vaccination campaigns. More studies aimed at assessing the effectiveness and impact of vaccination both on the individual and on the population level, with longer followup, are needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:An exemption from institutional review board approval was determined by the Israeli Ministry of Health as part of an active epidemiological investigation, based on use of anonymous data only and no medical intervention.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData availability statement The data that support the findings of this study originates from the Israel ministry of health. National age-group level vaccination data: https://data.gov.il/dataset/covid-19/resource/57410611-936c-49a6-ac3c-838171055b1f Aggregated town-level and age groups vaccination data is available at: https://data.gov.il/dataset/covid-19/resource/12c9045c-1bf4-478a-a9e1-1e876cc2e182 Aggregated GSA -level infection, hospitalization and vaccination data is available at: https://data.gov.il/dataset/covid-19/resource/d07c0771-01a8-43b2-96cc-c6154e7fa9bd Some restrictions apply to the availability of parts of the data used in the analysis and so are not publicly available.